• AO/PI Double Staining: A New Era for Translational Cell Deat

  2026-05-28

  Explore how the AO/PI Double Staining Kit from APExBIO empowers translational researchers to dissect cell death mechanisms with unprecedented clarity, bridging mechanistic insight and workflow strategy. Drawing on recent melanoma research and advanced cell models, this thought-leadership article goes beyond conventional product pages to chart a strategic path from biological rationale to clinical relevance.

• IRF4-Mediated B Cell Activation in ESCC: TLS and TRAF2 Dynam

  2026-05-27

  Zheng et al. reveal that tertiary lymphoid structures (TLS) rich in IRF4+ B cells independently predict favorable survival in esophageal squamous cell carcinoma (ESCC). The study uncovers a competitive interaction between CD40 and STING for TRAF2 binding, which drives IRF4-mediated B cell activation through non-canonical NF-κB signaling, illuminating new avenues for biomarker and therapeutic development.

• ARID1A-Driven Resistance Networks in Melanoma Drug Response

  2026-05-27

  This study uses integrative multi-omics to unravel how loss of ARID1A in melanoma reprograms signaling and gene expression, driving resistance to BRAF/MAPK inhibitors. The findings identify actionable resistance nodes and provide a framework for more durable therapeutic strategies.

• Cell Counting Kit-8 (CCK-8) Plus: Practical Assay Guidance

  2026-05-26

  Cell Counting Kit-8 (CCK-8) Plus enables accurate, sensitive cell proliferation and cytotoxicity quantification, streamlining workflows for drug screening and dehydrogenase activity measurement. It is ideal for applications needing rapid, WST-8 based cell viability assessment in multiwell formats, but should not be used where direct mechanistic or single-cell resolution is required.

• Structure-Based Discovery of NSP15 Inhibitors Against SARS-C

  2026-05-26

  This study applies virtual screening and molecular dynamics to identify natural product inhibitors of SARS-CoV-2 NSP15, highlighting thymopentin and oleuropein as potent candidates. The findings illuminate new directions for antiviral drug discovery by targeting viral immune evasion mechanisms.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetic S

  2026-05-25

  This study introduces a streamlined protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) with robust self-renewal and differentiation capacity. The innovation offers a more accurate, scalable in vitro model for pharmacokinetic research, addressing key limitations of traditional animal models and cancer-derived cell lines.

• Bufuralol Hydrochloride in Advanced Cardiovascular Pharmacol

  2026-05-25

  Bufuralol hydrochloride is redefining cardiovascular pharmacology research with its dual role as a non-selective β-adrenergic receptor antagonist and a probe for hiPSC-derived organoid models. This article unpacks optimized workflows, protocol benchmarks, and troubleshooting strategies for leveraging APExBIO's high-purity compound in translational β-adrenergic modulation studies.

• HR-LCMS/MS Reveals Astragalus dasyanthus as a Glabrol Source

  2026-05-24

  This study introduces a streamlined HR-LCMS/MS-based workflow for rapid identification of autophagy-inducing compounds in plant extracts. The authors demonstrate the method's utility by discovering Astragalus dasyanthus as a novel producer of glabrol, with implications for autophagy and metabolic research.

• Intestinal TM6SF2 Deficiency Drives MASH via the Gut–Liver A

  2026-05-23

  This study uncovers that loss of TM6SF2 specifically in intestinal epithelial cells promotes metabolic dysfunction-associated steatohepatitis (MASH) by disrupting gut barrier integrity, altering microbiota, and elevating lysophosphatidic acid (LPA) signaling. These findings reveal a mechanistic link between intestinal lipid metabolism and liver inflammation, highlighting new avenues for therapeutic intervention targeting the gut–liver axis.

• Tetraethylammonium Chloride: Applied Workflows in Vascular a

  2026-05-22

  Tetraethylammonium chloride (TEAC) enables high-resolution dissection of potassium channel pathways, giving researchers precision control in vascular and metabolic experiments. Leveraging APExBIO’s high-purity TEAC, scientists can streamline protocols, probe channelopathies, and troubleshoot challenging ion conduction assays with data-driven confidence.

• Synergistic Induction of Cell Death in RCC via SGI-1027 and

  2026-05-22

  This study demonstrates that combining the methuosis inducer SGI-1027 with the mTOR inhibitor everolimus induces both apoptosis and pyroptosis in renal cancer cells by disrupting lysosomal membrane integrity. The findings provide new mechanistic insights and highlight a promising therapeutic strategy to overcome drug resistance in advanced renal cell carcinoma.

• 5-Methyl-CTP: Enhancing mRNA Synthesis for Advanced Vaccines

  2026-05-21

  5-Methyl-CTP empowers researchers to synthesize mRNA with superior stability and translation efficiency, driving innovations in vaccine platforms and gene expression analysis. Explore cutting-edge workflows, troubleshooting insights, and real-world applications that set this modified nucleotide apart in mRNA-based drug development.

• Ridaforolimus: Applied Protocols for mTOR Inhibition in Canc

  2026-05-21

  Ridaforolimus (Deforolimus, MK-8669) is a selective mTOR inhibitor enabling robust, reproducible workflows for apoptosis, proliferation, and angiogenesis studies in cancer research. This guide delivers protocol refinements, troubleshooting strategies, and integration of recent machine learning-driven senolytic insights for maximum experimental reliability.

• Tetraethylammonium Chloride: Precision in K+ Channel Researc

  2026-05-20

  Tetraethylammonium chloride (TEAC) empowers researchers to interrogate potassium channel function with unmatched specificity, supporting both classic and emerging applications in physiology and pharmacology. This guide unpacks experimental workflows, troubleshooting strategies, and actionable insights for maximizing reproducibility and selectivity in ion conduction and vascular research.

• Lactobacillus gasseri Modulates Colitis via NR1I3-E-cadherin

  2026-05-20

  Qian et al. (2024) demonstrate that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by regulating E-cadherin expression through the NR1I3 pathway. This mechanistic insight clarifies how targeted probiotic intervention can reinforce the intestinal barrier, offering a foundation for novel IBD therapies.

8671 records 13/579 page Previous Next First page 上5页 1112131415 下5页 Last page